SEC 13F Intelligence

Foresite Capital Management IV, LLC / KURA

Foresite Capital Management IV, LLC’s Kura Oncology Inc Position

Does Foresite Capital Management IV, LLC own Kura Oncology Inc (KURA)? Not currently — the last reported position was 816.9K shares worth $5M in Q2 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$5M
Q2 2025
Shares
816.9K
% of Portfolio
+3.81%
Quarters Held
23
position exited

Position History KURA

Reported value by quarter
Q4 ’19: $935,000Q4 ’19Q1 ’20: $925,000Q2 ’20: $21MQ3 ’20: $40MQ3 ’20Q4 ’20: $59MQ1 ’21: $52MQ2 ’21: $39MQ2 ’21Q3 ’21: $35MQ4 ’21: $26MQ1 ’22: $30MQ1 ’22Q2 ’22: $34MQ3 ’22: $25MQ4 ’22: $23MQ4 ’22Q1 ’23: $23MQ2 ’23: $20MQ3 ’23: $17MQ3 ’23Q4 ’23: $27MQ1 ’24: $39MQ2 ’24: $38MQ2 ’24Q3 ’24: $36MQ4 ’24: $15MQ1 ’25: $7MQ1 ’25Q2 ’25: $5Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q2 2025816.9K$5M+3.81%
Q1 20251.11M$7M+6.61%
Q4 20241.73M$15M+13.83%
Q3 20241.85M$36M+23.62%
Q2 20241.85M$38M+25.59%
Q1 20241.85M$39M+19.94%
Q4 20231.85M$27M+13.44%
Q3 20231.85M$17M+9.37%
Q2 20231.85M$20M+9.62%
Q1 20231.85M$23M+11.74%
Q4 20221.85M$23M+9.81%
Q3 20221.85M$25M+8.13%
Q2 20221.85M$34M+9.13%
Q1 20221.85M$30M+8.32%
Q4 20211.85M$26M+5.33%
Q3 20211.85M$35M+5.10%
Q2 20211.85M$39M+5.21%
Q1 20211.85M$52M+6.26%
Q4 20201.81M$59M+6.41%
Q3 20201.31M$40M+9.04%
Q2 20201.31M$21M+10.39%
Q1 202093.0K$925,000+1.14%
Q4 201968.0K$935,000+0.40%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Foresite Capital Management IV, LLC’s full portfolio or all institutional holders of KURA.